CENCORA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 222 USD | -0.19% |
|
-0.22% | +8.09% |
| Jul. 09 | Baird Adjusts Cencora's Price Target to $285 From $280, Keeps Outperform Rating | MT |
| Jul. 09 | TD Cowen Adjusts Cencora's Price Target to $271 From $265, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Calendar
2024-07-31
- Q3 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
222
USD
Average target price
256.7
USD
Spread / Average Target
+15.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.09% | 43.72B | |
| -5.35% | 181B | |
| -5.23% | 100B | |
| -7.75% | 65.01B | |
| +16.45% | 45.75B | |
| -9.21% | 44.8B | |
| +11.97% | 29.01B | |
| +17.98% | 26.03B | |
| -5.34% | 24.28B | |
| -11.10% | 22.26B |
- Stock Market
- Equities
- COR Stock
- News Cencora, Inc.
- Baird Adjusts Cencora's Price Target to $285 From $280, Keeps Outperform Rating